Department für Radiologische Diagnostik und Therapie

Klinik für Strahlenheilkunde

Robert Koch Str. 3
79106 Freiburg
Tel: 0049-761-270-9461 Fax: 0049-761-270-9472
Email anca.grosu@uniklinik-freiburg.de


Wissenschaftliche Mitarbeiterinnen und Mitarbeiter

  • Prof. Dr. med. Anca-Ligia Grosu, Ärztliche Direktorin
  • Prof. Dr. Felix Momm, Leitender Oberarzt
  • Dr. med. Susanne Bartelt, OÄ
  • Prof. Dr. med. Michael Henke, Leiter Sektion Klinische Studien
  • Dr. med. Marianne Schmucker, Geschäftsführende Oberärztin
  • Dr. med. Karl Henne, OA
  • Dr. med. Cornelia Kluftinger
  • Dr. medic/IM Temeschburg Carmen Martini, OÄ
  • Prof. Dr. med. Ursula Nestle
  • Dr. med. Jutta Scholber, OÄ
  • Dr. med. Inge Uhlig, OÄ
  • Dr. med. Christina Hanser
  • Dr. med. Marc-Benjamin Messmer
  • Dr. med. univ. Dusan Milanovic
  • Dr. med. Tanja Schimek-Jasch
  • Eva Schubert, Assistenzärztin
  • Dr. med. Andreas Thomsen
  • Dr. /VAK Moskau Natascha Volegova-Neher
  • Dr. med. Nicole Wiedenmann
  • Dr. rer.nat. Gregor Bruggmoser, Leitender Physiker
  • Dr. rer. nat. Norbert Hodapp
  • Dr. rer. nat. Michael Kollefrath
  • Dipl. Phys. Sophie Küchler
  • Dr. rer. nat. Fred Röhner
  • Dr. rer. nat. Rolf Wiehle
  • Dr. med. Felix Heinemann, Leiter Klinische und Administrative Informatik
  • Sonja Adebahr, Assistenzärztin
  • Simon Kirste, Assistenzarzt
  • Prof. Dr. med. Gabriele Niedermann, Leiterin Sektion Strahlenbiologie
  • Tanja Schimeck-Jasch, Assistenzärztin
  • Andreas Schlotmann, Assistenzarzt
  • Dr. rer. nat. Elke Firat
Einträge in der Rubrik "Who is Who"

Finanzierung

  • Studie zur IMRT-Qualitätssicherung in der klinischen Routine

Wissenschaftliche Projekte und Forschungsvorhaben


  • ACCRA
  • Elucidation of the functions of TPPII in conditional TPPII knockout mice
  • Induzierbare Immundefizienz mittels HIF-1-Nef. Teilprojekt B4, SFB 620
  • Panitumumab
    • Projektleitung: Henke M - Projektleitung in der Klinik für Strahlenheilkunde
    • Laufzeit: 2008 bis 2015
    • Details zum Projekt

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Astner S, Dobrei-Ciuchendea M, Essler M, Bundschuh R, Sai H, Schwaiger M, Molls M, Weber W, Grosu AL: Effect of 11C-Methionine-Positron Emission Tomography on Gross Tumor Volume Delineation in Stereotacitc Radiotherapy of Skull Base Meningiomas Int J Radiat Oncol, 2008; 72 (4): 1161-1167.
  • Atanasov AG, Leiser D, Roesselet C, Noti M, Corazza N, Schoonjans K, Brunner T: Cell cycle-dependent regulation of extra-adrenal glucocorticoid synthesis in murine intestinal epithelial cells. Faseb J, 2008; 22 (12): 4117-4125. : http://dx.doi.org/10.1096/fj.08-114157
  • Bartelt S, Weber WA, Grosu AL: PET in der Strahlentherapie von Hirntumoren Der Nuklearmediziner, 2008; 31: 51-54.
  • Bauer VL, Braselmann H, Henke M, Mattern D, Walch A, Unger K, Baudis M, Lassmann S, Huber R, Wienberg J, Werner M, Zitzelsberger HF: Chromosomal changes characterize head and neck cancer with poor prognosis J Mol Med-jmm, 2008; 86 (12): 1353-1365.
  • Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M: Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. Jama-j Am Med Assoc, 2008; 27 (299): 914-924.
  • Bernhard EJ, Brunner TB: Progress towards the use of HIV protease inhibitors in cancer therapy. Cancer Biol Ther, 2008; 7 (5): 636-637.
  • Bieler A, Mantwill K, Holzmüller R, Jürchott K, Kaszubiak A, Stärk S, Glockzin G, Lage H, Grosu AL, Gansbacher B, Holm PS: Impact of radiation therapy on the oncolytic adenovirus dl520: Implications on the treatment of glioblastoma Radiother Oncol, 2008; 86: 419-427.
  • Bruggmoser G, Saum R: Sättigungsverhalten von Ionisationskammern PTB-Bericht, 2008; 5: 37-43.
  • Brumatti G, Yon M, Castro FA, Bueno-da-Silva AE, Jacysyn JF, Brunner T, Amarante-Mendes GP: Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide. Exp Cell Res, 2008; 314 (3): 554-563. : http://dx.doi.org/10.1016/j.yexcr.2007.11.003
  • Brunner TB, Geiger M, Grabenbauer GG, Lang-Welzenbach M, Mantoni TS, Cavallaro A, Sauer R, Hohenberger W, McKenna WG: Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. J Clin Oncol, 2008; 26 (16): 2699-2706. : http://dx.doi.org/10.1200/JCO.2007.15.2355
  • Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R: Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Strahlenther Onkol, 2008; 184 (1): 15-22. : http://dx.doi.org/10.1007/s00066-008-1787-5
  • Didichenko SA, Spiegl N, Brunner T, Dahinden CA: IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood, 2008; 112 (10): 3949-3958. : http://dx.doi.org/10.1182/blood-2008-04-149419
  • Drognitz O, Henne K, Weissenberger Ch, Bruggmoser G, Göbel H, Hopt UT, Frommhold H, Ruf G: Long-term results after intraoperative Radiation therapy for gastric cancer Int J Radiat Oncol, 2008; 70 (3): 715-721.
  • Golcher H, Brunner T, Grabenbauer G, Merkel S, Papadopoulos T, Hohenberger W, Meyer T: Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol, 2008; 34 (7): 756-764. : http://dx.doi.org/10.1016/j.ejso.2007.11.012
  • Gubler M, Brunner TJ, Zehnder M, Waltimo T, Sener B, Stark WJ: Do bioactive glasses convey a disinfecting mechanism beyond a mere increase in pH? Int Endod J, 2008; 41 (8): 670-678. : http://dx.doi.org/10.1111/j.1365-2591.2008.01413.x
  • Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, Seeger W, Lohmeyer J: Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med, 2008; 205 (13): 3065-3077. : http://dx.doi.org/10.1084/jem.20080201
  • Hofer U, Baenziger S, Heikenwalder M, Schlaepfer E, Gehre N, Regenass S, Brunner T, Speck RF: RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol, 2008; 82 (24): 12145-12153. : http://dx.doi.org/10.1128/JVI.01105-08
  • Holzapfel K, Müller SA, Seidl Ch, Grosu AL, Schwaiger M, Senekowitsch-Schmidtke R: Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCAP and PC3 Strahlenther Onkol, 2008; 6: 319-324.
  • Huai J, Firat E, Nil A, Million D, Gaedicke S, Kanzler B, Freudenberg M, van Endert P, Köhler G, Pahl HL, Aichele P, Eichmann K, Niedermann G: Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice. P Natl Acad Sci Usa, 2008; 105: 5177-5182.
  • Hupalowska A, Kalaszczynska I, Hoffmann S, Tsurumi C, Kubiak JZ, Polanski Z, Chiemerych M: Metaphase I arrest in LT/sv mouse oocytes involves the spindle assembly checkpoint Biol Reprod, 2008; 79: 1102-1110.
  • Jakob S, Corazza N, Diamantis E, Kappeler A, Brunner T: Detection of apoptosis in vivo using antibodies against caspase-induced neo-epitopes. Methods, 2008; 44 (3): 255-261. : http://dx.doi.org/10.1016/j.ymeth.2007.11.004
  • Janzarik W, Müller K, Lübbert M, Spreer J, Trippel M, Uhlig I, Weiller C, Rauer S: Occurrence of a germinoma 22 years after resection of a mature cerebral teratoma J Neuro-oncol, 2008; 88: 217-219.
  • Karamitopoulou E, Tornillo L, Zlobec I, Cioccari L, Carafa V, Borner M, Schaffner T, Brunner T, Diamantis I, Zimmermann A, Terracciano L: Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. Am J Clin Pathol, 2008; 130 (5): 780-786. : http://dx.doi.org/10.1309/AJCP35FDCAVANWMM
  • Kassahn D, Brunner T, Corazza N: Distinct but complementary roles of Fas ligand and Bim in homeostatic T cell apoptosis. Cell Cycle, 2008; 7 (21): 3469-3471.
  • Klautke G, Brunner TB: Radiotherapy in pancreatic cancer. Strahlenther Onkol, 2008; 184 (11): 557-564. : http://dx.doi.org/10.1007/s00066-008-1865-8
  • Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P: Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial J Thorac Oncol, 2008; 3 (9): 994-102.
  • Langen KJ, Tatsch K, Grosu AL, Jacobs AH, Weckesser M, Sabri O: Diagnostik von Hirntumoren mit radioaktiv markierten Aminosäuren Deutsches Ärzteblatt, 2008; 105 (4): 55-61.
  • Mantoni TS, Schendel RR, Rodel F, Niedobitek G, Al-Assar O, Masamune A, Brunner TB: Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Biol Ther, 2008; 7 (11): 1806-1815.
  • Mastino A, Basu S, Brunner T, Ricci JE, Diederich M: Long live the cell death! Cell Death Differ, 2008; 15 (8): 1330-1332. : http://dx.doi.org/10.1038/cdd.2008.38
  • Mattenberger H, Fraissler G, Brunner T, Herk P, Hermann L, Obernberger I: Sewage sludge ash to phosphorus fertiliser: variables influencing heavy metal removal during thermochemical treatment. Waste Manage, 2008; 28 (12): 2709-2722. : http://dx.doi.org/10.1016/j.wasman.2008.01.005
  • Meier I, Merkel S, Papadopoulos T, Sauer R, Hohenberger W, Brunner TB: Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Int J Radiat Oncol, 2008; 70 (5): 1408-1417. : http://dx.doi.org/10.1016/j.ijrobp.2007.08.053
  • Misra SK, Mohn D, Brunner TJ, Stark WJ, Philip SE, Roy I, Salih V, Knowles JC, Boccaccini AR: Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials, 2008; 29 (12): 1750-1761. : http://dx.doi.org/10.1016/j.biomaterials.2007.12.040
  • Muller J, Sidler D, Nachbur U, Wastling J, Brunner T, Hemphill A: Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Int J Cancer, 2008; 123 (8): 1797-1806. : http://dx.doi.org/10.1002/ijc.23755
  • Polanski Z, Motosugi N, Tsurumi C, Hiragai T, Hoffmann S: Hypomethylation of paternal DNA in the late mouse zygote is not essential for development Int J Dev Biol, 2008; 52 (2-3): 295-298.
  • Ryjkov VL, Brodeur M, Brunner T, Smith M, Ringle R, Lapierre A, Ames F, Bricault P, Dombsky M, Delheij P, Lunney D, Pearson MR, Dilling J: Direct mass measurement of the four-neutron halo nuclide 8He. Phys Rev Lett, 2008; 101 (1): 012501-012501.
  • Schaefer A, Kremp S, Hellwig D, Rübe C, Kirsch CM, Nestle U: A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data Eur J Nucl Med Mol I, 2008; 35: 1989-1999.
  • Schneider OD, Loher S, Brunner TJ, Uebersax L, Simonet M, Grass RN, Merkle HP, Stark WJ: Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B, 2008; 84 (2): 350-362. : http://dx.doi.org/10.1002/jbm.b.30878
  • Semrau R, Hansemann K, Adam M, Andratschke N, Brunner T, Heinzelmann F, Hildebrandt G, Vordermark D, Zips D: Quality of training in radiation oncology in Germany. Results of a 2006 survey. Strahlenther Onkol, 2008; 184 (5): 239-244. : http://dx.doi.org/10.1007/s00066-008-1821-7
  • Smith M, Brodeur M, Brunner T, Ettenauer S, Lapierre A, Ringle R, Ryjkov VL, Ames F, Bricault P, Drake GW, Delheij P, Lunney D, Sarazin F, Dilling J: First Penning-trap mass measurement of the exotic halo nucleus 11Li. Phys Rev Lett, 2008; 101 (20): 202501-202501.
  • Suttmann H, Grgic A, Lehmann J, Zwergel U, Kamradt J, Gouverneur E, Pinkert J, Stöckle M, Kirsch CM, Nestle U: Combining 153Sm-Lexidonam and Docataxel for the Treatment of Patients with Hormone-Refractory Prostate Cancer: First Experience Cancer Biother Radio, 2008; 23 (5): 609-618.
Reviews/Übersichtsartikel in wissenschaftlichen Fachzeitschriften:
  • Nieder C, Astner S, Mehta M, Grosu AL, Molls M: Improvement, Clinical Course and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma Am J Clin Oncol-canc, 2008; 31 (3): 300-305.
  • Weber W, Grosu AL, Cerznin J: Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol, 2008; 5: 160-170.
Buchbeiträge:
  • Grosu AL, Oesterreicher E, Fauser C, Lumenta C, Arnold WJ: Vestibular Schwannoma (Acoustic Neuroma) In: Radiotherapy for non-malignant disorders. Contemporary Concepts and clinical results Berlin Heidelberg New York: Springer Verlag, 2008; 629-653.
Kurzbeiträge / short communications:
  • Bennett C, Henke M, Lai S: Erythropoiesis-Stimulating Agents in the Treatment of Cancer-Associated Anemia. In Reply Jama-j Am Med Assoc, 2008; 300 (24): 2855-2857.
Vorträge:
  • Grosu AL: Strahlentherapie bei Tumoren der Orbita und vorderen Sehbahn 2008 (Orbita interdisziplinär, Freiburg).
  • Grosu AL: Aktuelle Möglichkeiten und differenzieller Einsatz der palliativen Strahlentherapie 2008 (Fachsymposium: "Therapieoptionen beim hormonrefraktären Prostatakarzinom", Freiburg, Prostata-Zentrum-Südbaden).
  • Grosu AL: Biologisch gesteuerte Strahlentherapie 2008 (114. Kongress der Deutschen Gesellschaft für Innere Medizin, Wiesbaden).
  • Grosu AL: PET in Radiation Oncology with emphasis on radiation treatment planning, hypoxia and dose painting. 2008 (Oncology Seminar, MAASTRO clinic, Maastricht).
  • Grosu AL: PET zur Bestrahlungsplanung 2008 (DEGRO ÖGRO, Wien).
  • Grosu AL: Tumorhypoxie in der Bildgebung 2008 (DEGRO ÖGRO, Wien).
  • Grosu AL: Neue Entwicklungen in der Strahlentherapie 2008 (Fortbildung Ärztlicher Kreisverein, Freiburg).
  • Grosu AL: Strahlentherapie bei Weichteilsarkomen: Neue Behandlungskonzepte, neue Techniken. 2008 (Freiburger Tumorforum, Aktuelle Konzepte zur Lokaltherapie bei Sarkomen).
  • Grosu AL: Neue Aspekte in der Strahlentherapie von Gliomen 2008 (Gliomtherapie 2008 Standards und aktuelle Studienergebnisse, Freiburg).
  • Grosu AL: Integration bildgebender Verfahren in die Planung und das Monitoring der Strahlentherapie 2008 (Studium Generale der Universität Freiburg und Volkshochschule Freiburg).
  • Grosu AL: Hochpräzision in der Strahlentherapie des Prostatakarzinoms 2008 (Prostatazentrum Südbaden).
  • Grosu AL: Strahlentherapie entzündlicher Orbitaerkrankungen 2008 (Orbita interdisziplinär, Freiburg).
  • Grosu AL: The potential of modern imaging techniques in defining the radiotherapy target V 2008 (ESTRO, Göteborg, Schweden).
  • Grosu AL: PET in Radiation Treatment Planning 2008 (Distinguished Lecture, Institute of Cancer Research, London).
  • Grosu AL: Was gibt es Neues in der Radiotherapie von ZNS-Tumoren 2008 (15. Interdisziplinäres Symposium Neuroradiologie, Freiburg).
  • Grosu AL: Zur Problematik der Zielvolumendefinition in der Neuroonkologie 2008 (Workshop zur Konformations-Bestrahlungsplanung, Limburg).
  • Grosu AL: Stereotaktische Strahlentherapie / Radiochirurgie im Körperstammbereich 2008 (Freiburger Tumorforum).
  • Grosu AL: Aktuelle Aspekte der LINAC-Radiochirurgie und Strahlentherapie 2008 (11. Freiburger Forum Stereotaktische Neurochirurgie).
  • Grosu AL: Radiation therapy and functional Imaging 2008 (Siemens IGRT Symposium).
  • Grosu AL: Niedriggradige Gliome 2008 (28. Deutscher Krebskongress, Wissen Teilen Chancen Nutzen).
  • Grosu AL: Hirnmetastasen 2008 (Hirntumorkonferenz Freiburg).
  • Grosu AL: PET in Radiation Treatment Planning 2008 (Distinguished Lecture, Institute of Cancer Research, London).
  • Henke M: Anemia - Cancer - Erythropoietin 2008 (Inaugural Distinguished Lecture in Cancer Policy, Northwestern University, R.H. Lurie Comprehensive Cancer Center, Chicago, USA).
Konferenzbeiträge:
  • Blau CA, Miller CP, Lowe KA, Mattern D, Valliant-Saunders K, Urban N, Henke M: Predictive testing for erythropoietin induced tumor progression in head and neck cancer J Clin Oncol, 2008; 26: 579s (ASCO).
  • Brink I, Baier P, Jüttner E, Paulus T, Narayanan M, Podbielski U, Weber W.A, Hentschel M: Asessment of hypoxia in esophageal carcinoma using 18F-MISO PET. J Nucl Med, 2008; 49 Suppl. 1: 113P.
  • Firat E, Huai J, Tsurumi C, Gaedicke S, Niedermann G: Untersuchungen zur Rolle des Proteasekomplexes TPPII bei Zellalterung, Tumorgenese und der zellulären Strahlenantwort anhand von TPPII-defizienten Mäusen Strahlenther Onkol, 2008; 184: 48-48.
  • Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, Salzwimmer M, Whiley M, Emmerson L, Berger D: Palifermin significantly reduces severe oral mucositis in subjects with resected locally advanced head and neck cancer undergoing post-operative concurrent radio-chemotherapy Radiother Oncol, 2008; 88 Suppl. 2: S152 (ESTRO27, September 14-18, 2008. Göteborg).
  • Henke M, Bennett CL, McKoy JM, Edwards BJ, Courtney DM, West DP, Samaras AT, Sartor AO, Spiegel DM: The importance of timely and appropriately-sized pharmacovigilance studies in the detection of safety signals: Lessons learned from the erythropoiesis stimulating agents (ESAs) controversy J Clin Oncol, 2008; 26: 318s (ASCO).
  • Hentschel M, Podbielski U, Baier P, Paulus T, Narayanan M, Jüttner E, Weber WA, Brink I: 15O-H2O-PET analysis of blood flow in esophageal cancer J Nucl Med, 2008; 49 Suppl. 1: 446P.
  • Kaden M, Momm F, Schimek-Jasch T, Henke M: Gemcitabine in the parallel appliqued radiochemotherapy of the advanced NSCLC Strahlenther Onkol, 2008; 184 Suppl. S1: 130 (14th Annual Congress of the Deutschen-Gesellschaft-fur-Radioonkologie/25th Annual Conference of the Osterreichischen-Gesellschaft-fur-Radioonkologie-Radiobiologie-und-Medizinische-Radiophysik, NOV 15-).
  • Le Q, Kim H, Schneider, Murakozy G, Skladowski, Reinisch S, Chen Y, Hickey M, Lizambri R, Henke M: Palifermin reduces severe oral mucositis in subjects with locally advanced head and neck cancer undergoing chemoradiotherapy Int J Radiat Oncol, 2008; 72 (1) Suppl. 1: S32-S33 (50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and Oncology Boston, MA, SEP 21-25, 2008).
  • McKoy JM, Sartor AO, Henke M, West DP, Courtney DM, Carson KR, Edwards BJ, Samaras AT, Bennett CL: Erythropoiesis stimulating agents (ESAs): An overview of safety-related findings from the Research on Adverse Drug Events and Reports (RADAR) project J Clin Oncol, 2008; 26: 370s (ASCO).
  • Schimek-Jasch T, Pajonk F, Henke M: Radiochemotherapy of the anal-carcinoma - Freiburg results Strahlenther Onkol, 2008; 184 Suppl. S1: 87 (14th Annual Congress of the Deutschen-Gesellschaft-fur-Radioonkologie/25th Annual Conference of the Osterreichischen-Gesellschaft-fur-Radioonkologie-Radiobiologie-und-Medizinische-Radiophysik, NOV 15-).

Besondere wissenschaftliche Aktivitäten
Verbände und Fachgesellschaften:
  • Bruggmoser G: Dosimetrie kleiner Bestrahlungsfelder, AK 6809 im DIN, 01.01.2008.

Abschlussarbeiten
Promotionen
  • Adebahr S: Selektion und Identifizierung leukämiezellbindender Peptidliganden (Erstgutachter/in Prof. Dr. med. Martin Trepel , Zweitgutachter/in Prof. Dr. med. Michael Henke), 2008.
  • Julia von Brocke: Validierung molekularer Marker für das Therapieansprechen bei neoadjuvant behandelten Patienten mit Rektumkarzinom (Erstgutachter/in Prof. Dr. med. Martin Werner, Zweitgutachter/in Prof. Dr. med. Michael Henke), 2008.




Gastwissenschaftler:

  • Balagur Anna, Moldawien, Modawien, 03.11.2008 bis 30.11.2008
  • Prof. Dr. Branislav Jeremic, MD. PhD, IAEA (International Atomic Energy Agency), Wien, Gastvortrag: "Radiation oncology of lung cancer: Why do we fail", 21.08.2008
  • Prof. Dr. Nina Mayr, Chair of the Department of Radiation Medicine, Ohio State University, USA, Gastvortrag: "Anatomical Functional MRI in Cervical Cancer and Their Significance for Radiation Therapy", 25.06.2008